Effect of Bacopa monniera on liver and kidney toxicity in chronic use of opioids

Phytomedicine

Volumn 16, Issue 10, 2009, Pages 897-903

  Sumathi, T ^a   Niranjali Devaraj, S ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Bacopa monniera; Kidney toxicity; Liver toxicity; Morphine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BACOPA MONNIERI EXTRACT; CREATININE; GAMMA GLUTAMYLTRANSFERASE; MORPHINE; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACOPA MONNIERI; CHRONIC TOXICITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALS; BACOPA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG EVALUATION, PRECLINICAL; DRUG-INDUCED LIVER INJURY; KIDNEY; KIDNEY DISEASES; LIVER; MALE; MORPHINE; MORPHINE DEPENDENCE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR;

BACOPA MONNIERI; RATTUS;

EID: 69849113834     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.03.005     Document Type: Article

References (35)

1. Bergmeyer H.U., Bower G.N., Horder Jr. M., and Moss D.W. Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase. Clin. Chim. Acta 70 (1976) F19-F42
2. Bergmeyer H.U. IFCC methods for the measurement of catalytic concentrations of enzymes. Part3. IFCC method for alanine aminotransferase(L-alanine:2-Oxoglutarate aminotransferase). Clin. Chim. Acta 105 (1980) 147-157
3. Borzelleca J.F., Elge Jr. J.L., Harris J.S., Johnson D.N., Terrill J.B., and Belleville A. Toxicology evaluation of mu-agonists. Part: Assessment of toxicology following 30 days of repeated oral dosing of male and female rats with levo-alpha-acetylmethadol HCL(LAAM). J. Appl. Toxicol. 14 (1994) 435-446
4. Caraway W.T. Uric acid. In: Seligson D. (Ed). Standard Methods of Clinical Chemistry vol. 4 (1963), New York, Academic Press 239-247
5. Channa S., Dar A., Yaqoob M., Anjum S., Sultani Z., and Rahman A. Broncho-vasodilatory activity of fractions and pure constituents isolated from Bacopa monniera. J. Ethnopharmacol. 86 (2003) 27-35
6. Chowdhuri D.K., Parmar D., Kakkar P., Shukla R., Seth P.K., and Srimal R.C. Anti-stress effects of bacosides of Bacopa monnieri: modulation of HSP to expression, SoI and cytochrome P450 activity in rat brain. Phytother. Res. 16 (2002) 639-645
7. Coughtrie M.W., Ask B., Rane A., Burchell B., and Hume R. The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme. Biochem. Pharmacol. 38 (1989) 3273-3280
8. Dar A., and Channa S. Calcium antagonistic activity of Bacopa monniera on vascular and intestinal smooth muscles of rabbit and guinea pig. J. Ethnopharmacol. 66 (1999) 167-174
9. Elangovan V., Govindasamy S., Ramamoorthy N., and Balasubramanian K. In-vitro studies on the anticancer activity of Bacopa monniera. Fitoterapia 66 (1995) 211-215
10. Jain P., Khanna N.K., Trehan T., Pendse V.K., and Godhwani J.L. Anti-inflammatory effects of an Ayurvedic preparation, Brahmi Rasayan, in rodents. Indian J. Exp. Biol. 32 (1994) 633-636
11. King J. The phosphohydrolysases - acid and alkaline phosphatase. In: Van D. (Ed). Practical in Clinical Enzymology (1965), Nostrand Co. Ltd., London 191-208
12. King J. The dehydrogenases or oxido reductase-lactate dehydrogenase. In: Van D. (Ed). Practical in Clinical Enzymology (1965), Nostrand Co. Ltd., London 83-93
13. Lurie E., Soloviova A., Alyabieva T., Kaplun A., Panchenko L., and Shvets V. Effect of novel aromatic derivative of GABA on lipid peroxidation in chronically morphinized rats. Biochem. Mol. Biol. Int. 36 (1995) 13-19
14. Macpherson R.D. The pharmacological basis of contemporary pain management. Pharmacol. Ther. 88 (2000) 163-185
15. Milne R.W., McLean C.F., Mather L.E., Nation R.L., Runciman W.B., Rutten A.J., and Somogyu A.A. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine. J. Pharmacol. Exp. Ther. 8 (1997) 181-186
16. Nadkarni K.M. Indian Materia Medica (1976), Popular Prakashan Pvt. Ltd., Mumbai pp. 624-625
17. Nagamatsu K., Onho Y., Ikebuchi H., Takahashi A., Terao T., and Takanaka A. Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. Biochem. Pharmacol. 35 (1986) 3543-3548
18. Natelson S., Scott M.L., and Beffa C. A rapid method for the estimation of urea in biological fluids. Am. J. Clin. Pathol. 21 (1951) 275-281
19. Owen J.A., Igg T.B., Scardrett F.J., and Stemart I.P. Determination of creatinine in serum or plasma and urine, a critical examination. Biochem. J. 58 (1954) 426-437
20. Pacifici G.M., Bencini C., and Rane A. Presystemic glucuronidation of morphine in humans and rhesus monkeys: subcellular distribution of the UDP-glucuronyl transferase in the liver and intestine. Xenobiotica 16 (1986) 123-128
21. Panchenko L.F., Pirozhkov S.V., Nadezhdin A.V., Baronets V.I., and Usmanova N.N. Lipid peroxidation, peroxyl radical scavenging system of plasma and liver and heart pathology in adolescence heroin users. Vopr. Med. Khim. 45 (1999) 501-506
22. Roodenrys S., Booth D., Bulzoni S., Phipps A., Micallef C., and Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 27 (2002) 279-281
23. Rosalki B., and Rau D. Serum gamma glutamyl transpeptidase activity in alcoholism. Clin. Chim. Acta 39 (1972) 41-47
24. Sairam K., Rao C.V., Babu M.D., and Goel R.K. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine 8 (2001) 423-430
25. Samiulla D.S., Prasanth D., and Amit A. Mast cell stabilizing activity of Bacopa monniera. Fitoterapia 72 (2001) 284-285
26. Singh H.K., and Dhawan B.N. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn(Brahmi). Indian J. Pharmacol. 29 (1997) S359-S365
27. Singhal P.C., Sharma P., Sanwal V., Prasad A., Kapasi A., Ranjan R., Franki N., Reddy K., and Gibbons N. Morphine modulates proliferation of kidney fibroblasts. Kidney Int. 53 (1998) 350-357
28. Stain-Texier F., Sandouk P., and Scherrann J.M. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of rat. Drug. Metab. Dispos. 26 (1998) 383-387
29. Stough C., Lloyd J., Clarke J., Downey A.L., Hutchison C.W., Rodgers T., and Nathan P.J. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacolology 156 (2001) 481-484
30. Sumathi T., Nayeem M., Balakrishna K., Veluchamy G., and Niranjali Devaraj S. Alcoholic extract of Bacopa monniera reduces the in-vitro effects of morphine withdrawal in guinea pig ileum. J. Ethnopharmacol. 82 (2002) 75-81
31. Sumathi T., Balakrishna K., Veluchami G., and Niranjali Devaraj S. Inhibitory effect of Bacopa monniera on morphine induced pharmacological effects in mice. Nat. Prod. Sci. 13 1 (2007) 46-53
32. Tolman K.G. Hepatotoxicity of non-narcotic analgesis. Am. J. Med. 105 (1998) 13S-19S
33. Tripathi Y.B., Chaurasia S., Tripathi E., Upadhyay A., and Dubey G.P. Bacopamonniera Linn as an antioxidant; mechanism of action. Indian J. Exp. Biol. 34 (1996) 523-526
34. Vanderlann J.W., Krajnc-Franker M.A., and Van Loveren H. Immunotoxicology screening of morphine and methadone in an extended 28 day study in rats. Int. J. Immunopharmacol. 17 (1995) 535-543
35. Way E.L. Review and overview of four decades of opiate research. Adv. Biochem. Psychopharmacol. 20 (1979) 3-27